Sodium Oxybate/Potassium Oxybate/Calcium Oxybate/Magnesium Oxybate

羟丁酸钠/羟丁酸钾/羟丁酸钙/羟丁酸镁

Report date: 2025/04/10 16:09:34

Base Information

Drug NameSodium Oxybate/Potassium Oxybate/Calcium Oxybate/Magnesium Oxybate
Drug Alias Name羟丁酸钠+羟丁酸钾+羟丁酸钙+羟丁酸镁Sodium Oxybate + Potassium Oxybate + Calcium Oxybate + magnesium Oxybate羟丁酸钠●羟丁酸钾●羟丁酸钙●羟丁酸镁Sodium Oxybate-Potassium Oxybate-Calcium Oxybate-Magnesium OxybateSodium Oxybate●Potassium Oxybate●Calcium Oxybate●Magnesium Oxybate +[9] 
ClassificationSmall molecules
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor agonists
TargetsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsSleepinessCataplexyNarcolepsy +[6] 
Global Approved IndicationsSleepinessCataplexyNarcolepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/07/21
Country/TerritoryCzechiaBelgiumUnited States +[9] 
CombinationsYes Sodium Oxybate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJazz Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesLeiden University Medical CenterJazz Pharmaceuticals PlcJazz Pharmaceuticals Ireland Ltd
Inactive CompaniesN/A
Active IndicationsSleepinessCataplexyNarcolepsy +[5] 
Inactive IndicationsIdiopathic Hypersomnia

Other Information

ATC CodeN/A
Related LinksN/A